Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05932693
Other study ID # 2000035551_a
Secondary ID 2U54DA036151-11
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date November 1, 2025

Study information

Verified date June 2024
Source Yale University
Contact Danielle Davis, PhD
Phone 203-974-7607
Email danielle.davis@yale.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot sensory experiment will examine cooling from comparable concentrations of WS-3 and menthol to determine appropriate concentrations to use in the main study.


Description:

This pilot study will establish low and high concentrations of both WS-3 and menthol concentrations to test in the main study. An anticipated 30 adult e-cigarette users will participate in one laboratory session during which participants will be exposed to e-liquids containing five different concentrations of two different cooling flavors without nicotine (10 e-liquids total). Participants will rate "coolness" using the generalized Labeled Magnitude Scale (gLMS). Using averages of participant ratings, we will select a low concentration of each constituent that is rated as more than "barely detectable" but less than "moderate" to ensure that cooling is weak but clearly perceptible. For the high concentration of each constituent, we will select a concentration that on average falls between "strong" and "very strong" to identify a strong cooling sensation while avoiding sensations that would also be uncomfortable.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date November 1, 2025
Est. primary completion date November 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - Able to read and write - Used e-cigarettes containing nicotine - Use e-cigs in past 30 days Exclusion Criteria: - Known hypersensitivity to propylene glycol - Pregnant or lactating females - Uncontrolled asthma - Nut/e-liquid flavorant allergy - Current marijuana (tetrahydrocannabinol) vaping + E-cigarette or vaping use Associated Lung Injury (EVALI) symptoms

Study Design


Related Conditions & MeSH terms


Intervention

Other:
E-liquid coolant (WS-3, 0.05%)
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.05%.
E-liquid coolant (WS-3, 0.1%)
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.1%.
E-liquid coolant (WS-3, 0.5%)
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.5%.
E-liquid coolant (WS-3, 1.0%)
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 1.0%.
E-liquid coolant (WS-3, 2.0%)
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 2.0%.
E-liquid coolant (menthol, 0.05%)
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.05%.
E-liquid coolant (menthol, 0.1%)
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.1%.
E-liquid coolant (menthol, 0.5%)
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.5%.
E-liquid coolant (menthol, 1.0%)
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 1.0%.
E-liquid coolant (menthol, 2.0%)
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 2.0%.
E-liquid coolant (WS-23, 0.05%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.05%.
E-liquid coolant (WS-23, 0.1%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.1%.
E-liquid coolant (WS-23, 0.5%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.5%.
E-liquid coolant (WS-23, 1.0%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 1.0%.
E-liquid coolant (WS-23, 2.0%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 2.0%.
E-liquid coolant (WS-23, 4.0%)
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 4.0%.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Yale University National Institute on Drug Abuse (NIDA)

References & Publications (1)

Lim J, Wood A, Green BG. Derivation and evaluation of a labeled hedonic scale. Chem Senses. 2009 Nov;34(9):739-51. doi: 10.1093/chemse/bjp054. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Coolness: Score change in coolness of each e-cigarette condition (16 conditions in total) Difference in overall flavor intensity, coolness, sweetness and harshness/irritation at each e-cigarette condition as measured by the computerized Generalized Labeled Magnitude Scale (gLMS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Generalized Labeled Magnitude Scales (gLMS) are category ratio scales with seven semantic labels: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable", positioned quasi-logarithmically as per empirically determined semantic magnitudes on a 0-100 scale (strongest imaginable at the 100 end). Following administration of e-cigarette condition 1 (at 10 minutes), then 5 minutes post administration of each e-cigarette condition, up to 85 minutes (condition 16)
See also
  Status Clinical Trial Phase
Completed NCT04219189 - The Acute Effect of Vaping on Food Intake N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Terminated NCT04083469 - Identifying Student Opinion Leaders to Lead E-cigarette Interventions N/A
Completed NCT05473585 - Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2 N/A
Recruiting NCT04662658 - Hyperpolarized Xenon-129 MR Imaging of the Lung Phase 1/Phase 2
Recruiting NCT05482581 - The Impact of Policies Regarding E-cigarette on Adolescents and Young Adults' Cognition and Behavior for E-cigarette
Completed NCT05477888 - Psychometric Properties of the Chinese Version of Penn State [Electronic] Cigarette Dependence Index
Active, not recruiting NCT05120466 - Media Literacy for High School Tobacco Prevention N/A
Completed NCT05081843 - Pittsburgh and Rural Area High School Tobacco Prevention N/A
Active, not recruiting NCT04946825 - Quit Smoking Study for People Who Use E-Cigarettes Phase 2
Recruiting NCT04974580 - Research and Innovation to Stop E-cigarette/Vaping in Young Adults Phase 4
Not yet recruiting NCT06264154 - The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers N/A
Completed NCT05431387 - A Study of Cytisinicline for Vaping Cessation in Adult Smokers Phase 2
Completed NCT04854616 - Cessation of Smoking Trial in the Emergency Department N/A
Recruiting NCT05199480 - Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health Early Phase 1
Completed NCT04150510 - Assessment of Smoking, Vaping, and Alcohol Consumption Behavior
Completed NCT04249219 - Responses to E-Cigarette Advertising Early Phase 1
Recruiting NCT04188197 - Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes Phase 3
Recruiting NCT05869318 - Respiratory Effects of E-Cigarettes in Obese Youth N/A
Recruiting NCT05432830 - Sex Differences in E-cig Perception: Study 1 N/A